Solaris Resources Inc. (CVE:SLS – Get Free Report)’s share price dropped 2.7% during trading on Monday . The stock traded as low as C$5.95 and last traded at C$6.15. Approximately 53,313 shares traded hands during trading, a decline of 60% from the average daily volume of 132,199 shares. The stock had previously closed at C$6.32.
Solaris Resources Stock Down 2.7 %
The company has a fifty day moving average price of C$6.15 and a 200 day moving average price of C$6.15.
About Solaris Resources
SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.
Read More
- Five stocks we like better than Solaris Resources
- Stock Dividend Cuts Happen Are You Ready?
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- How to Plot Fibonacci Price Inflection Levels
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- How to Invest in the FAANG Stocks
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with MarketBeat.com's FREE daily email newsletter.
